The Absorption, Metabolism and Excretion of [14C]D-0316 in Human

NCT04464551 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Non-small Cell Lung

Interventions

DRUG: [14C]D-0316 suspension

Sponsor

Betta Pharmaceuticals Co., Ltd.